Top

Published in:

01-04-2013 | Editorial

Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change direction

Author: José-Artur Paiva

Published in: Intensive Care Medicine | Issue 4/2013

Excerpt

Trouillet et al.’s [1] landmark paper proposed a simple strategy for selecting the initial therapy of patients suspected of having ventilation-associated pneumonia (VAP). The findings of that study indicated that the duration of mechanical ventilation (≥7 days) and the recent use of antibiotics are the two key factors favouring potentially resistant microorganisms as causative agents for ICU-acquired pneumonia. …

Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C (1998) Ventilator-associated pneumonia caused by potentially drug resistant bacteria. Am J Respir Crit Care Med 157:531–539PubMed

ATS/IDSA (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated and health care associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef

Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, Niederman M, Rello J (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk. Intensive Care Med. doi:10.1007/s00134-012-2808-5

Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH (2008) Predictors of 30-day mortality and hospital costs in patient with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 134:1208–1216CrossRef

Koo SH, Kwon KC, Cho HH, Sung JY (2010) Genetic basis of multi-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J Lab Med 30:498–506PubMedCrossRef

Kumarasamy KK, Toleman MA, Walsh TR et al (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect Dis 10:597–602PubMedCrossRef

Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N′Doye B, Pittet D, Richtmann R, Seta WH, van der Meer JWM, Voss A (2011) Society’s failure to protect a precious resource: antibiotics. Lancet 378:369–371PubMedCrossRef

Damas P, Layios N, Seidel L, Nys M, Melin P, Ledoux D (2011) Severity of ICU-acquired pneumonia according to infectious microorganisms. Intensive Care Med 37:1128–1135PubMedCrossRef

Dellit T, Owens R, McGowan J et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177PubMedCrossRef

10.

Niederman MS, Soulountsi V (2011) De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Clin Chest Med 32:517–534PubMedCrossRef

11.

Leggieri N, Rida A, François P, Schrenzel J (2010) Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis 23:311–319PubMed

12.

Pletz MW, Wellinghausen N, Welte T (2011) Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 37:1069–1076PubMedCrossRef

Title: Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change direction
Author: José-Artur Paiva
Publication date: 01-04-2013
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 4/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-012-2811-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change direction

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2013

“Benign” superior vena cava syndrome

Defining ARDS: do we need a mandatory waiting period?

Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

Erratum to: Bladder tissue oxygen tension monitoring in pigs subjected to a range of cardiorespiratory and pharmacological challenges

Goal-directed fluid resuscitation in acute pancreatitis: shedding light on the penumbra by dynamic markers of preload?